Chemsex Knowledge Gap at the Prescription Counter

Only about one-third of pharmacy professionals could cite prescription drugs associated with chemsex contexts.

By
Kerri Miller
May 19, 2026
4 min

Conexiant

At a Glance

Category	Detail
Condition	Chemsex-related knowledge and prevention, including extended sessions and specific substances.
Key Mechanisms	Use of psychoactive substances to enhance sexual activity, potential drug interactions, and harm reduction, including specific examples.
Target Population	Community pharmacy professionals in urban and near-urban settings in France, with emphasis on demographics.
Care Setting	Community pharmacies.

Key Highlights

80% of pharmacy professionals had heard of chemsex, but only 67% could define it.
11% reported learning about chemsex through formal education.
69% were unable to manage potential chemsex-related drug interactions.
84% considered current informational tools inadequate.
57% proposed professional training as a strategy for improvement.
Mean knowledge score was 13.8 on a theoretical 29-point scale.

Guideline-Based Recommendations

Diagnosis

Identify chemsex-related substance use and associated risks.

Management

Provide training on chemsex prevention and harm reduction strategies.
Address stigma and improve attitudes towards chemsex discussions.

Monitoring & Follow-up

Assess knowledge gaps and attitudes towards chemsex among pharmacy staff.

Risks

Recognize potential drug interactions and overdose risks in chemsex contexts.

Patient & Prescribing Data

Individuals engaging in chemsex and at risk for HIV/STIs.

Pharmacists should support patients with preexposure prophylaxis and infection-risk reduction strategies, including counseling on specific substances.